Accelerate & de-risk programs including COVID-19, create differentiation & improve patient outcomes. Development of a New Chemical Entity and [...]
July 17, 2019 Key Learning Objectives CNS drug delivery opportunitiesNose-to-brain drug delivery challengesUtilization of animal models for CNS drug deliveryAdvantages [...]
If you are planning on submiting samples please download and submit the sample submission form.
This presentation examines SEM-EDS and Raman Spectroscopy as a means to accelerate generic drug applications. Presented on October 2017 at the 6th Medicon Valley Inhalation Symposium (MVIC) by Julie D. Suman, PhD.
This poster focuses on the utilization of the SPE© automated Raman spectroscopy system and its ability to measures the count, size and shape of particles, and chemical characterization.
This presentation examines global regulatory requirements along with regulatory approaches for bioequivalence and an overview of FDA drug specific guidance.
This presentation examines regulatory approaches for bioequivalence and a comparison of compendial testing and pharmaceutical equivalence for Brazil.
This document provides a sample outline of a model suspension nasal spray product program designed to meet expected storage, experiment and report expectations for regulatory submission.
This presentation gives perspective to understanding the rationale for nasal and pulmonary drug delivery and provides guidance for differentiating between device attributes for inhalation and nasal platforms.
Presented at RDD EUROPE 2015, this presentation takes a critical look at delivery systems and their life cycle management, including looking at the benefits and challenges.